ONO-4578

· Ono Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for ONO-4578, covering 2024-08-07 to 2026-03-27. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer [Phase 2]

See pricing